Related Experiment Video

Updated: Aug 9, 2026

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells
06:54

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells

Published on: October 27, 2020

TGF-beta in cancer and as a therapeutic target

Jan Pinkas1, Beverly A Teicher

  • 1Genzyme Corporation, 1 Mountain Road, Framingham, MA 01721, United States.

Biochemical Pharmacology
|April 20, 2006
PubMed

Insights

Cancer progression involves genetic changes affecting cell processes and metastasis. Transforming growth factor-beta (TGF-β) promotes malignancy, making it a therapeutic target for antibody and kinase inhibitor treatments.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cell Biology

Background:

  • Cancer arises from genetic alterations impacting cellular functions like proliferation and apoptosis.
  • Metastasis, the spread of cancer, is a complex process involving tumor cell dissemination and growth in distant sites.
  • Transforming growth factor-beta (TGF-β), typically growth-suppressive, actively promotes malignant progression.

Purpose of the Study:

  • To elucidate the role of genetic changes in cancer development and metastasis.
  • To understand the multifaceted involvement of TGF-β in malignant transformation and progression.
  • To identify TGF-β and its receptors as potential therapeutic targets.

Main Methods:

  • Analysis of genetic alterations in cancer progression.
  • Investigation of cellular processes affected by genetic changes (proliferation, apoptosis, differentiation, genomic stability).
  • Examination of the role of TGF-β in key metastatic steps and tumor microenvironment modulation.

Main Results:

  • Genetic aberrations disrupt fundamental cellular processes critical for malignancy.
  • TGF-β transitions from a suppressive role to a pro-malignant factor.
  • TGF-β actively drives angiogenesis, extracellular matrix deposition, immunosuppression, and metastasis growth.

Conclusions:

  • Genetic changes are fundamental to cancer development and metastasis.
  • TGF-β plays a critical oncogenic role in promoting malignant behaviors.
  • Targeting TGF-β signaling pathways with therapeutics offers a promising strategy against cancer.

More Related Videos

Defining Gene Functions in Tumorigenesis by Ex vivo Ablation of Floxed Alleles in Malignant Peripheral Nerve Sheath Tumor Cells09:37

Defining Gene Functions in Tumorigenesis by Ex vivo Ablation of Floxed Alleles in Malignant Peripheral Nerve Sheath Tumor Cells

Published on: August 25, 2021

Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma06:15

Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma

Published on: October 27, 2014

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.